Avillion LLP

Life sciences venture capital major Abingworth is reportedly looking to raise up to $1.5bn in funding to be deployed for clinical development projects partnered with pharma companies in return for fut

AstraZeneca PLC and fellow UK partner Avillion LLP 's bid to expand the market for Airsupra has been boosted by "overwhelming" data from a study halted early after the their first-in-class asthma re

AstraZeneca PLC 's asthma rescue medication Airsupra has received the green light from US regulators, boosting the UK major's respiratory franchise which is feeling the pinch due to declining revenues

A US Food and Drug Administration advisory committee overwhelmingly voted 8 November that adult efficacy data for Avillion LLP and AstraZeneca PLC ’s novel budesonide/albuterol sulfate product coul